Patents by Inventor Andrew Stoll

Andrew Stoll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Omega-3 fatty acids in the treatment of depression
    Publication number: 20050267212
    Abstract: The present invention is directed to a method of treating patients with major depression by administering omega-3 fatty acids. These may be administered in a substantially purified form, as part of a pharmaceutical composition, or as part of a larger molecule, e.g., a triacylglycerol, which releases free fatty acid after ingestion by a patient. The present invention is also directed to triacylglycerols which are esterified at the gamma cardon of glycerol to phosphocholine and at either the alpha or beta carbon of glycerol to an omega-3 fatty acid. These “omega-3 phoshatidylcholines” are also used in the treatment of patients with major depression.
    Type: Application
    Filed: February 7, 2005
    Publication date: December 1, 2005
    Inventor: Andrew Stoll
  • Omega-3 fatty acids in the treatment of depression
    Patent number: 6852870
    Abstract: The present invention is directed to a method of treating patients with major depression by administering omega-3 fatty acids. These may be administered in a substantially purified form, as part of a pharmaceutical composition, or as part of a larger molecule, e.g., a triacylglycerol, which releases free fatty acid after ingestion by a patient. The present invention is also directed to triacylglycerols which are esterified at the gamma cardon of glycerol to phosphocholine and at either the alpha or beta carbon of glycerol to an omega-3 fatty acid. These “omega-3 phoshatidylcholines” are also used in the treatment of patients with major depression.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: February 8, 2005
    Inventor: Andrew Stoll
  • Omega-3 fatty acids in the treatment of depression
    Publication number: 20030012827
    Abstract: The present invention is directed to a method of treating patients with major depression by administering omega-3 fatty acids. These may be administered in a substantially purified form, as part of a pharmaceutical composition, or as part of a larger molecule, e.g., a triacylglycerol, which releases free fatty acid after ingestion by a patient.
    Type: Application
    Filed: February 27, 2002
    Publication date: January 16, 2003
    Inventor: Andrew Stoll